Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

NCT03817502 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Cariprazine
DRUG: Placebo

Sponsor

Gedeon Richter Plc.